Health And Pharma

Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

Clinical Trials

Imlunestrant Shows Promising Results Alone and with Verzenio in ER+, HER2- Breast Cancer

Clinical Trials

Breakthrough in First-Line Ovarian Cancer Treatment: KEYTRUDA and LYNPARZA Show Promise

Clinical Trials

Blenrep Combination Reduces Death Risk by 42% in Relapsed Multiple Myeloma

FDA & EMA

FDA Approves Durvalumab as the First and Only Immunotherapy for LSSC Lung Cancer

ONCOLife

How AI is Shaping Drug Discovery: LP-300 in Lung Cancer Treatment

ONCOLife

How Novel Immunotherapy IMNN-001 Could Change Ovarian Cancer Outcomes

ONCOLife

How the ARANOTE Trial Results Could Advance Prostate Cancer Treatment

ONCOLife

How Oncolytic Viruses Could Be a New Frontier in Transforming Cancer Treatment

Featured Articles

Elevation Oncology Partners with Synaffix in $368M Deal to Advance HER3 ADC Development

12 December 2024

Synaffix announces that it has entered into a licensing agreement with Elevation Oncology to develop EO-1022, a HER3-targeting Antibody-Drug Conjugate (ADC) leveraging Synaffix’s advanced platform technologies....

General Inception Acquires Enable Medicine to Drive AI-Led Drug Discovery Breakthroughs

12 December 2024

FDA Grants Breakthrough Status to Datopotamab Deruxtecan for EGFR-Mutated Lung Cancer

10 December 2024

Fixed-Duration Acalabrutinib Plus Venetoclax Achieves Superior 77% PFS in Untreated CLL

9 December 2024

Adding Blinatumomab to Chemotherapy Extends 96% DF Survival in Pediatric Leukemia

8 December 2024

Promising Sac-TMT Receives FDA Breakthrough Therapy Designation for Lung Cancer

7 December 2024

AI-Driven Cancer Therapy: Recursion Doses First Patient in REC-1245 Trial for Solid Tumors

6 December 2024

Trending Articles

FDA Grants Accelerated Approval to Bizengri for Treating NRG1+ Pancreatic Cancer and NSCLC

FDA & EMA | 6 December 2024

Durvalumab Granted FDA Priority Review for Muscle-Invasive Bladder Cancer Patients

FDA & EMA | 6 December 2024

AI-Powered PET/CT Analysis May Predict Side Effects of Immunotherapy in Lung Cancer

AI | 29 November 2024

The FDA Approves IMKELDI, the First Oral Liquid Form of Imatinib, for Leukemia

FDA & EMA | 27 November 2024

Roche Acquires Poseida in $1.5 Billion Deal to Advance Cell Therapy Innovation

Pharma | 28 November 2024

SKYSCRAPER-01 Trial Shows Safety of Tiragolumab Plus Atezolizumab in Lung Cancer

Clinical Trials | 26 November 2024

FDA Greenlights Revumenib for Relapsed Leukemia Treatment

ONCOLife | 23 November 2024

FDA Approves Ziihera as First Dual HER2-Targeted Therapy for Biliary Tract Cancer

ONCOLife | 22 November 2024

UK Researchers Launch Groundbreaking Study to Uncover Cancer Survival Secrets

ONCOLife | 19 November 2024

FDA Approves MI Cancer Seek Test for Targeted Cancer Therapy

ONCOLife | 9 November 2024

Overcoming Resistance in Cancer Treatment with Cytokine Therapies

ONCOLife | 8 November 2024

IMUNON’s Novel Immunotherapy IMNN-001 Enhances Survival in Ovarian Cancer

Clinical Trials | 7 November 2024

Novel Biomarker-Driven Treatments with ADCs in NSC Lung Cancer Management

ONCOLife | 5 November 2024

Role of CGP Testing in the Management of Cancer Treatment and Personalized Care

ONCOLife | 4 November 2024

Transforming Melanoma Treatment with DNA Plasmid Vaccine

Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global

Webinar

31 October 2024

FDA Approves First Targeted Therapy for IDH-Mutant Glioma with Companion Diagnostic

Biotech

21 October 2024

Targeting NBR1: New Biomarker Could Predict Immunotherapy Success in Liver Cancer

Biotech

20 October 2024

How Engineered Oncolytic Adenoviruses Could Transform Cancer Treatment

ONCOLife

15 October 2024

AI-Powered Cancer Drug LP-184 Receives FDA Fast-Track Designation for Glioblastoma

FDA Approves VYLOY™ as a New Targeted Therapy for Advanced Gastric and GEJ Cancer

FDA & EMA

19 October 2024

Sanofi and Orano Join Forces to Develop Novel Radioligand Therapies for Rare Cancers

Pharma

18 October 2024

FDA Approves Itovebi as First-Line Therapy for PIK3CA-Mutated Breast Cancer

ONCOLife

12 October 2024

Merlin Molecular Test Offers Hope for Melanoma by Reducing Unnecessary Surgeries

Biotech

11 October 2024

Bayer Expands Precision Oncology Portfolio with MOMA Therapeutics' KNOMATIC Platform

The Next Generation of ADCs and the Potential of ABBV-400 in Lung Cancer Treatment

ONCOLife

9 October 2024

The LUMINOSITY Trial And Exploring Novel Biomarker Targets in the Future of ADCs for NSCLC

ONCOLife

7 October 2024

The Future of Oncolytic Viruses and Their Role in Cancer Treatment

ONCOLife

3 October 2024

The Role of AI in the Future of Drug Discovery: Redefining Accuracy...

Digital Health

2 October 2024